サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：口腔がん迅速検査キットの世界市場2023-2030
市場調査レポート
商品コード
1296876

口腔がん迅速検査キットの世界市場2023-2030

Global Oral Cancer Rapid Test Kit Market 2023-2030

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
口腔がん迅速検査キットの世界市場2023-2030
出版日: 2023年05月25日
発行: Orion Market Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の口腔がん迅速検査キット市場は、予測期間中に4.1%のCAGRで成長すると予測されています。市場の成長は、口腔がんの有病率の増加や早期発見の必要性などの要因に起因しています。また、技術のさらなる進歩や研究開発への投資の増加も、口腔がん迅速検査キットの需要を促進すると予想されます。例えば、2020年10月、Sascan Meditech社は、OralScanと呼ばれるハンドヘルド口腔がんスクリーニング装置を発売しました。この装置は口腔がんの効果的なスクリーニングソリューションを提供し、早期発見とタイムリーな介入を可能にすることを目的としています。この開発は、ヘルスケア技術とがん検診の分野における努力と進歩を浮き彫りにしています。

セグメント別展望

ラボオンチップサブセグメントは予測期間中にかなりの市場成長を記録する

タイプ別セグメントの中で、ラボオンチップサブセグメントは予測期間中に大きな成長を記録すると予測されています。ラボオンチップ技術は、小型化、ポータブル、迅速な検査機能を提供し、ポイントオブケア診断に非常に適しています。このサブセグメントの成長は、その利便性、正確性、費用対効果に起因しています。ここ数年、ラボオンチップデバイスは、迅速で信頼性の高い結果を提供できることから、さまざまなヘルスケア現場で人気を博しています。

地域別展望

口腔がん迅速検査キットの世界市場では北米地域が大きなシェアを占めると予想される

これらの地域の中で、アジア太平洋地域は予測期間中、世界の口腔がん迅速検査キット市場で大きなシェアを占めると予測されています。この地域の市場成長は、主に口腔がんの有病率の増加や早期発見・診断に対する意識の高まりなどの要因によってもたらされます。さらに、早期診断と口腔がん治療におけるその特典に関する認識を広めるために政府が開始したイントロダクション・プログラムが大幅に増加しています。例えば、2023年4月、パンジャブ州は公的医療機関で口腔がんのスクリーニングを行う新たな取り組みを開始しました。報告書によると、口腔がんは国内で男性に最も多く見られるがんであり、国内では毎年かなりの症例が診断されています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Abbott Laboratories
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • F. Hoffmann-La Roche AG
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 口腔がん迅速検査キットの世界市場：タイプ別
    • オンクラート口腔がんLAB
    • ラボオンチップ
    • Insilixa検査
    • プレボチェック
  • 口腔がん迅速検査キットの世界市場：用途別
    • 病院
    • 診断センター
    • 研究センター

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics
  • Quidel Corp.
  • Siemens Healthineers
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.
  • Wantai BioPharm
図表

LIST OF TABLES

  • 1. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ONC ALERT ORAL CANCER LAB RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL LAB ON CHIP ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ORAL CANCER INSILIXA RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ORAL CANCER PREVO- CHECK RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ORAL CANCER RAPID TEST KIT FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL ORAL CANCER RAPID TEST KIT FOR DIAGNOSTIC CENTER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL ORAL CANCER RAPID TEST KIT FOR RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 14. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ONC ALERT ORAL CANCER LAB RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL LAB ON CHIP ORAL CANCER RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ORAL CANCER INSILIXA RAPID TEST KIT MARKET SHARE REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ORAL CANCER PREVO- CHECK RAPID TEST KIT MARKET SHARE REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL ORAL CANCER RAPID TEST KIT FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL ORAL CANCER RAPID TEST KIT FOR DIAGNOSTIC CENTER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL ORAL CANCER RAPID TEST KIT FOR RESEARCH CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL ORAL CANCER RAPID TEST KIT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD ORAL CANCER RAPID TEST KIT MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027371

Title: Global Oral Cancer Rapid Test Kit Market Size, Share & Trends Analysis Report by Type (Onc Alert Oral Cancer LAB, Lab on Chip, Insilixa Test, and Prevo-Check) and by Application (Hospitals, Diagnostic Center, and Research Centers) Forecast Period (2023-2030).

The global oral cancer rapid test kit market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of oral cancer and the need for early detection. Further advancements in technology and rising investments in research and development are also expected to fuel the demand for oral cancer rapid test kits. For instance, in October 2020, Sascan Meditech launched handheld oral cancer screening device called OralScan. The device aims to provide an effective screening solution for oral cancer, allowing for early detection and timely intervention. This development highlights the efforts and advancements made in the field of healthcare technology and cancer screening.

Segmental Outlook

The global oral cancer rapid test kit market is segmented based on its type and application. Based on the type, the market is segmented into onc alert oral cancer lab, lab on chip, insilixa test, and prevo-check. Based on the application, the market is categorized into hospitals, diagnostic centers, and research centers. Among the application segment, the hospital sub-segment is anticipated to hold a prominent share of the market owing to the rise in development of cancer specialty hospital.

Lab on Chip Sub-Segment to Register Considerable Market Growth During the Forecast Period

Among the type segment, the lab on chip sub-segment is anticipated to register significant growth during the forecast period. The lab on chip technology offers miniaturized, portable, and rapid testing capabilities, making it highly suitable for point-of-care diagnostics. The growth of this sub-segment is attributed to factors owing to its convenience, accuracy, and cost-effectiveness. Over the past few years, lab on chip devices have gained popularity in various healthcare settings due to their ability to deliver quick and reliable results.

Regional Outlooks

The global oral cancer rapid test kit market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these regions, Europe is anticipated to hold a prominent market share due to the presence of well-established healthcare infrastructure and increased awareness about oral cancer screenings. However, the Asia-Pacific region is projected to experience considerable growth in the oral cancer rapid test kit market due to rising healthcare expenditure, increasing awareness campaigns, and growing government initiatives for early cancer detection.

Global Oral Cancer Rapid Test Kit Market Growth, by Region 2022-2030

Source: OMR Analysis

The North American Region is anticipated to Hold a Significant Share in the Global Oral cancer rapid test kit Market

Among these regions, the Asia-Pacific region is anticipated to hold a significant share in the global oral cancer rapid test kit market during the forecast period. The regional market growth is primarily driven by factors including the increasing prevalence of oral cancer and rising awareness about early detection and diagnosis. Additionally, there is a considerable increase in the introduction programmes launched by the government to propogate awareness about early diagnosis and its benefits in treating oral cancer. For instance, in April 2023, Punjab has launched a new initiative to screen patients for oral cancer in the public health institutions. As per the report oral cancer is the most prevalent cancer in men in the country and significant cases of the disease are diagnosed each year in the country.

Market Players Outlook

The major companies serving the global oral cancer rapid test kit market include Abbott Laboratories, Becton, Thermo Fisher Scientific Inc., Trinity Biotech plc, Viome Life Sciences, Inc., Wantai BioPharm, Quest Diagnostics, Siemens Healthineers. These market players are considerably contributing to the market growth by adopting various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022 Viome Life Sciences, a biotechnology company launched a diagnostic test for oral and throat cancer that uses mRNA technology and an AI-powered platform.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global oral cancer rapid test kit market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. F. Hoffmann-La Roche AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Oral Cancer Rapid Test Kit Market by Type
    • 4.1.1. Onc Alert Oral Cancer LAB
    • 4.1.2. Lab on Chip
    • 4.1.3. Insilixa Test
    • 4.1.4. Prevo- Check
  • 4.2. Global Oral Cancer Rapid Test Kit Market by Application
    • 4.2.1. Hospitals
    • 4.2.2. Diagnostic Center
    • 4.2.3. Research Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Thermo Fisher Scientific Inc.
  • 6.3. F. Hoffmann-La Roche AG
  • 6.4. Beckman Coulter, Inc.
  • 6.5. Becton, Dickinson and Co.
  • 6.6. Bio-Rad Laboratories, Inc.
  • 6.7. Danaher Corp.
  • 6.8. GRAIL, LLC
  • 6.9. Henry Schein, Inc.
  • 6.10. Quest Diagnostics
  • 6.11. Quidel Corp.
  • 6.12. Siemens Healthineers
  • 6.13. Trinity Biotech plc
  • 6.14. Viome Life Sciences, Inc.
  • 6.15. Wantai BioPharm